Medical Technology Partner’s presentation is designed highlight what Medicare is proposing to do based on the Protecting Access to Medicare Act of April 1, 2014 with regard to clinical laboratory diagnostic tests in general and Laboratory Developed Tests in particular.

This presentation’s learning objectives are to alert participants that there are:

• Upcoming proposed changes in how Medicare proposes to pay for Clinical Diagnostic Laboratory Tests (CLDTs)
• Key reimbursement proposals that could affect Laboratory Developed Tests (LDTs)
• Easy ways to access the CMS source document and respond before  November 24, 2015